Serious or fatal injuries resulting from medication errors are commonplace among patients receiving drugs to treat primary pulmonary hypertension (PPH), a new study has found. According to research presented at an annual meeting of the American College of Chest Physicians, the majority of doctors and nurses who have administered the PPH drugs Flonan and Remodulin have witnessed errors in how the drugs were given to patients. More »
The law firm of Hissey Kientz, LLP is pleased to announce the launch of its new website, Herbal Fen Phen Lawyers. The site will serve as a news and information resource for individuals who may have suffered injuries such as primary pulmonary hypertension after using products marketed as “herbal Fen Phen” or other dietary supplements containing ephedra. More »
Researches at the University of Texas Southwestern Medical Center say that they have uncovered a circuit in the brain that may explain how fenfluramine—a diet drug once prescribed as part of Fen-Phen—works to suppress appetite. The scientists began their study in order to determine how Fen-Phen affects the brain and to find safer drugs that could be used to control appetite.
A new study of two recalled drugs that were part of the diet drug combination Fen-Phen showed that they can cause lasting damage to the heart. The study, published in the journal MBC Medicine, found that damage to the heart in patients who took Pondimin (fenfluramine) or Redux (dexfenfluramine) could persist for years after patients stopped taking the drugs.